Drug Trial Radar · NCT06366490
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Feb 12, 2026
Primary completion
Nov 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- PhotonPharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1 study to evaluate the safety and immunogenicity of Innocell, an autologous cellular immunotherapy made from patient-derived tumor cells, in female patients with recurrent epithelial ovarian cancer. Innocell autologous cellular immunotherapy consists of autologous tumor cells which have been inactivated using a proprietary light technology that inhibits cell replication while allowing for the cell to maintain antigen expression. These replication incompetent cells are then administered concurrently with an immunoadjuvant to stimulate a person's innate or adaptive immune response to vaccine antigens. This novel inactivation mechanism creates improved antigen presentation, specifically with presentation of the broad array of neoantigens unique to each patient's tumor.
Conditions
- Ovarian Cancer (OvCa)
Interventions
InnocellBiological
Innocell an autologous immunotherapy + CpG 1018 adjuvant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success rate of autologous manufacturingTime frame: Approximately 2 months from Enrollment to Manufacturing release
- Safety assessed by treatment emergent adverse eventsTime frame: From enrollment until 30 days after the last dose of Innocell
Locations
1 site in 1 country. Site status is shown where the registry gives one.
City of Hope
Duarte, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.